Telomerase reverse transcriptase (TERT) promoter mutations—found in up to 80% of IDH-wildtype and 28% of IDH-mutant glioblastomas—enable telomere maintenance and support cellular immortality [8,9,10]. Here, IDH1 is linked to glioblastoma.